IOB - Delayed Quote ? SEK Hansa Biopharma AB (publ) (0RC7.IL) Follow Compare 40.02 -0.75 (-1.84%) At close: 4:17 PM GMT+1 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 0RC7.IL 1D 5D -2.34% 1M -3.08% 3M -4.44% 6M 35.11% YTD 46.70% 1Y 45.32% 2Y -25.65% 5Y -69.32% All -3.07% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: 0RC7.IL View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Hansa Biopharma Reports Third Quarter and Interim January - September 2024 Financial Results PR Newswire ? 5 days ago Hansa Biopharma's HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial PR Newswire ? 15 days ago Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference PR Newswire ? last month Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis PR Newswire ? last month Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update PR Newswire ? 3 months ago Hansa Biopharma to host Q2 2024 interim results conference call PR Newswire ? 3 months ago Hansa Biopharma: increase in number of shares and votes PR Newswire ? 3 months ago Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial PR Newswire ? 4 months ago Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting PR Newswire ? 4 months ago Hansa Biopharma interim report January-March 2024 PR Newswire ? 6 months ago Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance PR Newswire ? 6 months ago View More
